34.00p+2.00 (+6.25%)18 Mar 2024, 16:40
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Destiny Pharma PLC Market & Company News

31.01.2024 18:28MOS, DEST, AAUEARNINGS AND TRADING: STV raises holding in Two Cities TelevisionAlliance
31.01.2024 07:00DESTClinical development updateRNS
22.01.2024 07:00DESTAppointment of Nominated Adviser and Sole BrokerRNS
04.01.2024 14:07DESTDestiny Pharma seeks to capitalise on XF-73 market potential in 2024Alliance
04.01.2024 07:00DESTYear End Business UpdateRNS
20.10.2023 07:00DESTGrant of Share OptionsRNS
19.10.2023 07:00DESTDirector/PDMR ShareholdingRNS
17.10.2023 11:15DESTDestiny Pharma celebrates study findings on "potent" flagship drugAlliance
17.10.2023 10:18ABDX, DEST, INXAIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 dataAlliance
17.10.2023 07:01DESTXF Pipeline Update MeetingRNS
17.10.2023 07:00DESTPublication of new microbiological data for XF-73RNS
10.10.2023 07:00DESTDirector/PDMR ShareholdingRNS
04.10.2023 12:34DESTDirector/PDMR ShareholdingRNS
27.09.2023 07:00DESTNotice of XF Pipeline Update MeetingRNS
20.09.2023 14:27DPA, ENET, DESTTRADING UPDATES: Dianomi swings to loss; Epwin revenue upAlliance
20.09.2023 07:00DESTInterim ResultsRNS
13.09.2023 15:48W7L, SUPR, PYXUK earnings, trading statements calendar - next 7 daysAlliance
23.08.2023 07:00DESTNotice of Interim ResultsRNS
31.07.2023 17:31IIP, DUKE, MXCTRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permitAlliance
31.07.2023 12:01DESTPublication of new data for XF-73RNS
25.07.2023 14:27DESTIN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to roleAlliance
25.07.2023 07:00DESTAppointment of new ChairmanRNS
19.07.2023 13:16DESTIN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resignsAlliance
19.07.2023 12:55DESTBoard changes including appointment of new CEORNS
07.07.2023 07:00DESTExercise of Options and Total Voting RightsRNS
06.07.2023 12:49DESTIN BRIEF: Destiny Pharma confirms phase 3 development for lead assetAlliance
06.07.2023 07:00DESTPositive findings from recent SAB meetingReach
29.06.2023 18:55RNEW, JSE, FARNTRADING UPDATES: Ecofin US Renewables expects to pay reduced dividendAlliance
29.06.2023 07:00DESTBusiness UpdateRNS
26.05.2023 15:27DESTDirector/PDMR ShareholdingRNS
26.05.2023 10:51KOO, DEST, POLXPolarean shares down despite narrowed annual loss and optimismAlliance
26.05.2023 07:00DESTDirector DealingRNS
25.05.2023 12:23DESTResult of Annual General MeetingRNS
25.05.2023 10:42GSK, DESTIN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exitAlliance
25.05.2023 07:00DESTDr Debra Barker Appointed Interim CEORNS
18.05.2023 15:03ZIN, VANQ, TBCGUK shareholder meetings calendar - next 7 daysAlliance
12.05.2023 12:24DESTGrant of Share OptionsRNS
02.05.2023 19:22PHE, DNE, MACFTRADING UPDATES: Macfarlane buys A&G Holdings for GBP3.6 millionAlliance
02.05.2023 07:00DESTPositive results from SPOR-COV® researchRNS
26.04.2023 16:10DESTPosting of Annual Report and Notice of AGMRNS
26.04.2023 10:05DESTExercise of Options and Total Voting RightsRNS
13.04.2023 13:59DESTIN BRIEF: Destiny Pharma annual loss widens as expenses growAlliance
13.04.2023 07:00DESTAudited results for year ended 31 December 2022RNS
06.04.2023 15:42XPP, TSCO, PZCUK earnings, trading statements calendar - next 7 daysAlliance
04.04.2023 07:00DESTLandmark data published on NTCD-M3RNS
03.04.2023 07:00DESTNotice of Results and Investor PresentationRNS
24.03.2023 07:00DESTLandmark XF-73 Phase 2 data published in journalRNS
16.03.2023 15:29DESTResult of General Meeting and Total Voting RightsRNS
16.03.2023 06:54DESTIN BRIEF: Destiny Pharma raises GBP7.3 million total in equity raiseAlliance
15.03.2023 16:02DESTResult of Open OfferRNS
06.03.2023 10:50DESTExercise of Options and Total Voting RightsRNS
06.03.2023 10:31DESTHolding(s) in CompanyRNS
28.02.2023 15:55DESTPosting of Circular and Notice of General MeetingRNS
27.02.2023 16:30DESTDirector/PDMR ShareholdingRNS
24.02.2023 14:28DESTDestiny shares fall on fundraise discount despite USD570 million dealAlliance
24.02.2023 13:32DESTIssue of EquityRNS
24.02.2023 13:32DESTAgreement with Sebela Pharmaceutical for NTCD-M3RNS
24.02.2023 11:00DESTPrice Monitoring ExtensionRNS
31.01.2023 11:00DESTPrice Monitoring ExtensionRNS
26.01.2023 10:10DESTExercise of Options and Total Voting RightsRNS
25.01.2023 20:03PRD, CRCL, PAYTRADING UPDATES: Appreciate gets court date; Corcel completes saleAlliance
25.01.2023 07:00DESTUS Center for Disease Control review paperReach
22.12.2022 11:25DESTDestiny Pharma on track for commercial agreement for NTCD-M3 drugAlliance
22.12.2022 09:05DESTSecond Price Monitoring ExtnRNS
22.12.2022 09:00DESTPrice Monitoring ExtensionRNS
22.12.2022 07:00DESTYear End Trading UpdateRNS
07.12.2022 17:35DESTDestiny Pharma eyes potential billion dollar returns from Nasal assetAlliance
07.12.2022 07:00DESTFDA/CDC highlight need for infection preventionsReach
07.12.2022 07:00DESTXF-73 Nasal final Phase 3 development plansRNS
02.12.2022 14:48DESTDirector DisclosureRNS
23.11.2022 07:00DESTAppointment of Corporate BrokerRNS
21.11.2022 14:19DESTEQS-News: Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infectionsEQS
18.11.2022 13:16DESTDirector Shareholding AmendmentRNS
15.11.2022 16:16DESTDestiny Pharma starts new drug study for its skin infection treatmentAlliance
15.11.2022 07:00DESTXF-73 advances to clinically enabling safety studyRNS
Showing 1 to 75 of 182